Our Commitment
Making life better goes beyond the medicines we make.
It’s at the very core of our business.
Delivering a deep pipeline through research, collaboration,
and personal experience, to improve the lives of the ones
we love the most.
Our strategy is to bring the very best science and medicine to our animal companions.
As one of the first pet biotech companies in the world, we develop breakthrough medicines for dogs, cat and horses.
We identify drugs, biologics, and targets that have been validated in humans and develop animal versions for pets. By leveraging the research and development investment in the existing human pharmaceuticals, doing so, we substantially increase the likelihood of success and decrease the cost and time required to develop breakthrough therapies for our animal family members.
We have a world class team experienced in both human and veterinary medicine. We have selected best practices from both fields, and focus on lean development. As a result, we develop most of our drugs and biologics for between $3 million to $5 million and in only 3 to 5 years.
Our goal is to transform veterinary medicine by developing best medicines for our best friends. By doing so, we believe we will create value for our patients, our veterinarians, employees, and shareholders.
